Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Takeda Pharmaceutical Li...

    NYSE: TAK · Real-Time Price · USD
    15.06
    -0.14 (-0.92%)
    At close: Jun 16, 2025, 3:59 PM
    15.01
    -0.37%
    After-hours: Jun 16, 2025, 06:00 PM EDT

    Takeda Pharmaceutical Statistics

    Share Statistics

    Takeda Pharmaceutical has 3.15B shares outstanding. The number of shares has increased by 1.03% in one year.

    Shares Outstanding

    n/a
    		 3.15B

    Shares Change (YoY)

    n/a
    		 1.03%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 4.55%

    Shares Floating

    n/a
    		 3.15B

    Failed to Deliver (FTD) Shares

    n/a
    		 1,460

    FTD / Avg. Volume

    n/a
    		 0.07%

    Short Selling Information

    The latest short interest is 6.24M, so 0.2% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.24M

    Short % of Shares Out

    n/a
    		 0.2%

    Short % of Float

    n/a
    		 0.2%

    Short Ratio (days to cover)

    n/a
    		 3.64

    Valuation Ratios

    The PE ratio is 45.02 and the forward PE ratio is 0.35. Takeda Pharmaceutical's PEG ratio is -0.82.

    PE Ratio

    n/a
    		 45.02

    Forward PE

    n/a
    		 0.35

    PS Ratio

    n/a
    		 1.52

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0.89

    P/FCF Ratio

    n/a
    		 27.53

    PEG Ratio

    n/a
    		 -0.82
    Financial Ratio History

    Enterprise Valuation

    Takeda Pharmaceutical has an Enterprise Value (EV) of 7,629B.

    EV / Sales

    n/a
    		 1.79

    EV / EBITDA

    n/a
    		 8.72

    EV / EBIT

    n/a
    		 10.65

    EV / FCF

    n/a
    		 32.38

    Financial Position

    The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.67.

    Current Ratio

    n/a
    		 1.11

    Quick Ratio

    n/a
    		 0.58

    Debt / Equity

    n/a
    		 0.67

    Debt / EBITDA

    n/a
    		 5.54

    Debt / FCF

    n/a
    		 20.56

    Interest Coverage

    n/a
    		 1.39

    Financial Efficiency

    Return on Equity is 1.98% and Return on Invested Capital is 4.44%.

    Return on Equity

    n/a
    		 1.98%

    Return on Assets

    n/a
    		 0.95%

    Return on Invested Capital

    n/a
    		 4.44%

    Revenue Per Employee

    n/a
    		 $86,519,388.81

    Profits Per Employee

    n/a
    		 $2,923,378.18

    Employee Count

    n/a
    		 49,281

    Asset Turnover

    n/a
    		 0.28

    Inventory Turnover

    n/a
    		 1.18

    Taxes

    Income Tax

    n/a
    		 -91.41B

    Effective Tax Rate

    n/a
    		 -173.15%

    Stock Price Statistics

    The stock price has increased by 14.35% in the last 52 weeks. The beta is 0.26, so Takeda Pharmaceutical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.26

    52-Week Price Change

    n/a
    		 14.35%

    50-Day Moving Average

    n/a
    		 14.72

    200-Day Moving Average

    n/a
    		 14.21

    Relative Strength Index (RSI)

    n/a
    		 55.13

    Average Volume (20 Days)

    n/a
    		 2,137,511

    Income Statement

    In the last 12 months, Takeda Pharmaceutical had revenue of 4,263.8B and earned 144.07B in profits. Earnings per share was 46.05.

    Revenue

    n/a
    		 4,263.8B

    Gross Profit

    n/a
    		 2,832.3B

    Operating Income

    n/a
    		 214.07B

    Net Income

    n/a
    		 144.07B

    EBITDA

    n/a
    		 874.6B

    EBIT

    n/a
    		 172.33B

    Earnings Per Share (EPS)

    n/a
    		 46.05
    Full Income Statement

    Balance Sheet

    The company has 457.8B in cash and 4,843.8B in debt, giving a net cash position of -4,386B.

    Cash & Cash Equivalents

    n/a
    		 457.8B

    Total Debt

    n/a
    		 4,843.8B

    Net Cash

    n/a
    		 -4,386B

    Retained Earnings

    n/a
    		 1,391.2B

    Total Assets

    n/a
    		 14,573B

    Working Capital

    n/a
    		 666.78B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 716.34B and capital expenditures -480.73B, giving a free cash flow of 235.61B.

    Operating Cash Flow

    n/a
    		 716.34B

    Capital Expenditures

    n/a
    		 -480.73B

    Free Cash Flow

    n/a
    		 235.61B

    FCF Per Share

    n/a
    		 150.61
    Full Cash Flow Statement

    Margins

    Gross margin is 66.43%, with operating and profit margins of 5.02% and 3.38%.

    Gross Margin

    n/a
    		 66.43%

    Operating Margin

    n/a
    		 5.02%

    Pretax Margin

    n/a
    		 1.24%

    Profit Margin

    n/a
    		 3.38%

    EBITDA Margin

    n/a
    		 20.51%

    EBIT Margin

    n/a
    		 5.02%

    FCF Margin

    n/a
    		 5.53%

    Dividends & Yields

    TAK pays an annual dividend of $0.51, which amounts to a dividend yield of 3.59%.

    Dividend Per Share

    n/a
    		 $0.51

    Dividend Yield

    n/a
    		 3.59%

    Dividend Growth (YoY)

    n/a
    		 -4%

    Payout Ratio

    n/a
    		 221.74%

    Earnings Yield

    n/a
    		 2.22%

    FCF Yield

    n/a
    		 7.27%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TAK.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $1151.25

    Lynch Upside

    n/a
    		 7544.42%

    Graham Number

    n/a
    		 3103.68

    Graham Upside

    n/a
    		 20508.76%

    Scores

    Altman Z-Score

    n/a
    		 0.62

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist